Skip to content
WeighLab

VivioMD vs Omzo

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

VivioMD

Provider comparison

Shoppers who want both compounded and FDA-approved GLP-1 options from one nationwide platform, and don't mind completing an intake before seeing price.

Semaglutide / month
Not disclosed
Tirzepatide / month
Not disclosed
Index 53/100 · Grade CChecked October 2026

Omzo

Provider comparison

Patients who want weight-loss care alongside other telehealth services and can confirm package duration before paying.

Semaglutide / month
$179Initial GLP-1 package; $299 follow-up package (supply duration unspecified)
Tirzepatide / month
$259Initial tirzepatide package; $399 follow-up package (supply duration unspecified)
Index 53/100 · Grade CChecked October 2026

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Both score 53/100 on the Cost-Efficiency Index. There is no score winner; compare the treatment you need, billing terms and state availability.

Check the difference in state access

VivioMD
49 states (excluding Louisiana)
Omzo
U.S. residents only; confirm state eligibility

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

VivioMD

Omzo

Semaglutide / month
VivioMD: Not disclosed
Omzo: $179Initial GLP-1 package; $299 follow-up package (supply duration unspecified)
Tirzepatide / month
VivioMD: Not disclosed
Omzo: $259Initial tirzepatide package; $399 follow-up package (supply duration unspecified)
Semaglutide / year (modeled)
VivioMD: —
Omzo: —
Tirzepatide / year (modeled)
VivioMD: —
Omzo: —
State availability
VivioMD: 49 states (excluding Louisiana)
Omzo: U.S. residents only; confirm state eligibility
Oral / sublingual option listed
VivioMD: Not listed
Omzo: Not listed
Brand-name access listed
VivioMD: Yes
Omzo: Yes
Provider facts checked
VivioMD: October 2026
Omzo: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

VivioMD

Shoppers who want both compounded and FDA-approved GLP-1 options from one nationwide platform, and don't mind completing an intake before seeing price.

Reasons to consider it

  • Offers branded and compounded treatment paths
  • Names OpenLoop as a clinical partner
  • Provider messaging and follow-up support

What to weigh up

  • No public medication price before assessment
  • Current terms do not identify the dispensing pharmacies
  • No medical director is named

Regulatory note: the FDA issued a warning letter to VivioMD Group LLC dba VivioMD in June 2026. We still list and link to VivioMD; you should know the letter is on the public record before you decide.

Omzo

Patients who want weight-loss care alongside other telehealth services and can confirm package duration before paying.

Reasons to consider it

  • Terms publish initial and follow-up consultation-and-medication package amounts
  • Compounded packages include consultation, medication, shipping and support
  • Offers a separate brand-name prescription route

What to weigh up

  • Package duration is not specified, so the published totals do not establish monthly medication prices
  • Initial packages cost less than follow-up packages
  • The compounding pharmacy and medical director are not named

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

VivioMDOmzo
Normalized Cost/Month
VivioMD:
45/100
Omzo:
45/100
Price Transparency
VivioMD:
20/100
Omzo:
54/100
Nationwide Access
VivioMD:
78/100
Omzo:
24/100
Formulation Options
VivioMD:
53/100
Omzo:
79/100
Clinical Oversight
VivioMD:
73/100
Omzo:
76/100
Contract Flexibility
VivioMD:
67/100
Omzo:
55/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

More provider matchups
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.